Interleukin-11 precursor
Interleukin-11 precursor Brand names, Interleukin-11 precursor Analogs
Interleukin-11 precursor Brand Names Mixture
- No information avaliable
Interleukin-11 precursor Chemical_Formula
C854H1411N253O235S2
Interleukin-11 precursor RX_link
http://www.rxlist.com/cgi/generic3/oprelvek.htm
Interleukin-11 precursor fda sheet
Interleukin-11 precursor msds (material safety sheet)
Interleukin-11 precursor Synthesis Reference
No information avaliable
Interleukin-11 precursor Molecular Weight
19047.2
Interleukin-11 precursor Melting Point
No information avaliable
Interleukin-11 precursor H2O Solubility
No information avaliable
Interleukin-11 precursor State
Liquid
Interleukin-11 precursor LogP
-0.070
Interleukin-11 precursor Dosage Forms
Powder for solution; Solution (subcutaneous injection)
Interleukin-11 precursor Indication
Increases reduced platelet levels due to chemotherapy
Interleukin-11 precursor Pharmacology
Oprelvekin is indicated for the prevention of severe thrombocytopenia and the reduction of the need for platelet transfusions following myelosuppressive chemotherapy in adult patients with nonmyeloid malignancies who are at high risk of severe thrombocytopenia. The primary hematopoietic activity of Oprelvekin is stimulation of megakaryocytopoiesis and thrombopoiesis. Oprelvekin has shown potent thrombopoietic activity in individuals with compromised hematopoiesis
Interleukin-11 precursor Absorption
No information avaliable
Interleukin-11 precursor side effects and Toxicity
No information avaliable
Interleukin-11 precursor Patient Information
No information avaliable
Interleukin-11 precursor Organisms Affected
Humans and other mammals
